Inogen, Inc. (INGN)

NASDAQ: INGN · IEX Real-Time Price · USD
6.68
-0.35 (-4.91%)
Mar 4, 2024, 4:00 PM EST - Market closed
-4.91%
Market Cap 163.74M
Revenue (ttm) 327.86M
Net Income (ttm) -132.50M
Shares Out 23.31M
EPS (ttm) -5.75
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 610,700
Open 7.04
Previous Close 7.03
Day's Range 6.47 - 7.06
52-Week Range 4.13 - 15.48
Beta 1.03
Analysts Hold
Price Target 7.50 (+12.28%)
Earnings Date Feb 27, 2024

About INGN

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrat... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Feb 14, 2014
Employees 1,026
Stock Exchange NASDAQ
Ticker Symbol INGN
Full Company Profile

Financial Performance

In 2023, Inogen's revenue was $315.66 million, a decrease of -16.32% compared to the previous year's $377.24 million. Losses were -$102.45 million, 22.3% more than in 2022.

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for INGN stock is "Hold." The 12-month stock price forecast is $7.5, which is an increase of 12.28% from the latest price.

Price Target
$7.5
(12.28% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results f...

6 days ago - Business Wire

Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

GOLETA, Calif.--(BUSINESS WIRE)--Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024.

4 weeks ago - Business Wire

Inogen Names Michael Bourque as New Chief Financial Officer

GOLETA, Calif.--(BUSINESS WIRE)--Inogen Names Michael Bourque as New Chief Financial Officer.

5 weeks ago - Business Wire

Inogen to Present at Upcoming Investor Conferences in November 2023

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management wil...

4 months ago - Business Wire

Inogen Announces Third Quarter 2023 Financial Results

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results f...

4 months ago - Business Wire

Inogen to Report Third Quarter 2023 Financial Results on November 7, 2023

GOLETA, Calif.--(BUSINESS WIRE)--Inogen to Report Third Quarter 2023 Financial Results on November 7, 2023.

5 months ago - Business Wire

Inogen Completes Acquisition of Physio-Assist

GOLETA, Calif.--(BUSINESS WIRE)--Inogen Completes Acquisition of Physio-Assist.

6 months ago - Business Wire

Inogen Announces CFO Transition Plan

GOLETA, Calif.--(BUSINESS WIRE)--Inogen Announces CFO Transition Plan. Names Mike Sergesketter as Interim Chief Financial Officer. Reaffirms 2023 Financial Guidance.

6 months ago - Business Wire

Inogen Recognized as a Finalist for Ragan's CSR & Diversity Awards Program

GOLETA, Calif.--(BUSINESS WIRE)--Inogen Recognized as a Finalist for Ragan's CSR & Diversity Awards Program.

7 months ago - Business Wire

Inogen Announces Second Quarter 2023 Financial Results

GOLETA, Calif.--(BUSINESS WIRE)--Inogen Announces Second Quarter 2023 Financial Results.

7 months ago - Business Wire

Inogen Achieves Best In Class 8-Year Expected Service Life Portable Oxygen Concentrators

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the introduction of...

7 months ago - Business Wire

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This MonthSilk Road Me

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Other symbols: AADIFGENSILKTHRX
8 months ago - Benzinga

Inogen Expands Its Respiratory Product Portfolio with Acquisition of Physio-Assist

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the company ha...

8 months ago - Business Wire

Inogen to Present at 43rd Annual William Blair Growth Stock Conference

GOLETA, Calif.--(BUSINESS WIRE)--Inogen to Present at 43rd Annual William Blair Growth Stock Conference.

10 months ago - Business Wire

Inogen Announces First Quarter 2023 Financial Results

GOLETA, Calif.--(BUSINESS WIRE)--Inogen Announces First Quarter 2023 Financial Results.

10 months ago - Business Wire

Inogen to Report First Quarter 2023 Financial Results on May 4, 2023

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report...

11 months ago - Business Wire

Inogen to Present at 22nd Annual Needham Virtual Healthcare Conference

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management wil...

11 months ago - Business Wire

Inogen to Present at KeyBanc Life Sciences & MedTech Investor Forum

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management wil...

1 year ago - Business Wire

Inogen to Provide Strategy Update on February 27, 2023

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will host a...

1 year ago - Business Wire

Inogen Announces Fourth Quarter and Full Year 2022 Financial Results

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results f...

1 year ago - Business Wire

Inogen Achieves Regulatory Milestones to Support Current and Future Products

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has achie...

1 year ago - Business Wire

Inogen Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Within Company Expectations

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced unaudited prelimi...

1 year ago - Business Wire

Inogen to Present at 41st Annual J.P. Morgan Healthcare Conference

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the company ...

1 year ago - Business Wire

Inogen to Present at Upcoming Investor Conferences in November 2022

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following invest...

1 year ago - Business Wire